Abstract:SUMMARY
Entosis is a mechanism of cell death that involves neighbor cell ingestion. This process occurs in cancers and promotes a form of cell competition, where winner cells engulf and kill losers. Entosis is driven by a mechanical differential that allows softer cells to eliminate stiffer cells. While this process can be induced by matrix detachment, whether other stressors can activate entosis is unknown. Here, we find that entosis is induced in adherent cells by glucose withdrawal. Glucose withdrawal leads… Show more
“…On the other hand, entosis may promote tumour progression in several ways. It may provide tumour cells with nutrients and thus assure their survival under the starved conditions of the tumour stroma . Entosis may also contribute to immune evasion.…”
Section: Discussionmentioning
confidence: 90%
“…Three biological factors triggering tumour cell cannibalism have been identified thus far, namely anchorage‐independent growth, aberrant proliferation and starvation, that is, lack of available glucose. Accordingly, it has been proposed that entosis may confer tumour suppression via selective killing of dissociating, hyperproliferative or glucose‐deprived cancer cells, notably at early tumour stages . On the other hand, entosis may promote tumour progression in several ways.…”
Canine oral malignant melanoma (COMM) is a potentially lethal cancer disease. We established primary cell lines from mostly amelanotic primary COMM and metastases and assessed lesions and derived cells for Melan A, PNL2 and CD146 expression. Then, migration and invasion of CD146‐enriched vs ‐depleted COMM cells were analysed. Epithelial‐to‐mesenchymal transition (EMT) was addressed by Vimentin‐staining and MMP2/MMP9 zymography. Phagocytic behaviour was analysed by histopathological examination and phagocytosis assay. While Melan A‐ and PNL2‐staining yielded inconsistent data, 100% of COMM sections and primary cells showed CD146 expression, suggesting that this protein may serve as a prognostic marker. An overall correlation between CD146‐expression and migration/invasion was not observed. All primary cell lines consistently expressed Vimentin and secreted biologically active MMP2, indicating that they had undergone EMT. Importantly, COMM sections exhibited cell‐in‐cell structures, and all primary cell lines exhibited phagocytic activity, supporting the concept that cell cannibalism may have a role in COMM progression.
“…On the other hand, entosis may promote tumour progression in several ways. It may provide tumour cells with nutrients and thus assure their survival under the starved conditions of the tumour stroma . Entosis may also contribute to immune evasion.…”
Section: Discussionmentioning
confidence: 90%
“…Three biological factors triggering tumour cell cannibalism have been identified thus far, namely anchorage‐independent growth, aberrant proliferation and starvation, that is, lack of available glucose. Accordingly, it has been proposed that entosis may confer tumour suppression via selective killing of dissociating, hyperproliferative or glucose‐deprived cancer cells, notably at early tumour stages . On the other hand, entosis may promote tumour progression in several ways.…”
Canine oral malignant melanoma (COMM) is a potentially lethal cancer disease. We established primary cell lines from mostly amelanotic primary COMM and metastases and assessed lesions and derived cells for Melan A, PNL2 and CD146 expression. Then, migration and invasion of CD146‐enriched vs ‐depleted COMM cells were analysed. Epithelial‐to‐mesenchymal transition (EMT) was addressed by Vimentin‐staining and MMP2/MMP9 zymography. Phagocytic behaviour was analysed by histopathological examination and phagocytosis assay. While Melan A‐ and PNL2‐staining yielded inconsistent data, 100% of COMM sections and primary cells showed CD146 expression, suggesting that this protein may serve as a prognostic marker. An overall correlation between CD146‐expression and migration/invasion was not observed. All primary cell lines consistently expressed Vimentin and secreted biologically active MMP2, indicating that they had undergone EMT. Importantly, COMM sections exhibited cell‐in‐cell structures, and all primary cell lines exhibited phagocytic activity, supporting the concept that cell cannibalism may have a role in COMM progression.
“…Like autophagy, this mechanism may support the long-term survival of tumour cells when detached from the extracellular matrix or exposed to nutrient starvation (Overholtzer et al 2007; Hamann et al 2017). Entosis occurs spontaneously in certain populations of cancer cells (e.g.…”
Section: Molecular Processes Implicated In the Generation Of Cellularmentioning
confidence: 99%
“…Entosis occurs spontaneously in certain populations of cancer cells (e.g. MCF-7 breast cancer cells) and can be further enhanced by glucose starvation (Durgan et al 2017; Hamann et al 2017). …”
Section: Molecular Processes Implicated In the Generation Of Cellularmentioning
confidence: 99%
“…At the molecular level, winner cells exhibit increased mechanical deformability, a phenotype controlled by the activity of the cellular actinomyosin network (Sun et al 2014). In response to glucose starvation, higher levels of AMPK pathway activity may inhibit the cytoskeletal regulator Ras-related C3 botulinum toxin substrate 1 (RAC1) or alter myosin contraction, leading to reduced mechanical deformability and ‘loser’ status (Hamann et al 2017). Thus, susceptibility to entosis may be governed by fluctuations in the metabolic state of the cell, providing a link between heterogeneous glycolytic metabolism/AMPK activity within a cellular population and susceptibility to entotic cell death.…”
Section: Molecular Processes Implicated In the Generation Of Cellularmentioning
The goal of chemotherapy is to induce homogeneous cell death within the population of targeted cancer cells. However, no two cells are exactly alike at the molecular level, and sensitivity to drug-induced cell death therefore varies within a population. Genetic alterations can contribute to this variability and lead to selection for drug resistant clones. However, there is a growing appreciation for the role of non-genetic variation in producing drug tolerant cellular states that exhibit reduced sensitivity to cell death for extended periods of time, from hours to weeks. These cellular states may result from individual variation in epigenetics, gene expression, metabolism and other processes that impact drug mechanism of action or the execution of cell death. Such population-level non-genetic heterogeneity may contribute to treatment failure and provide a cellular ‘substrate’ for the emergence of genetic alterations that confer frank drug resistance.
Although targeting cancer metabolism is a promising therapeutic strategy, clinical success depends on accurate molecular and metabolic subtyping.Here, this study reports two metabolism-based molecular subtypes associated with the ketogenic treatment of colon cancer: glycolytic (glycolysis + /ketolysis − ) and ketolytic (glycolysis + /ketolysis + ), which are manifested by distinct profiles of metabolic enzymes and mitochondrial dysfunction, and by different responses to ketone-containing interventions in vitro and in vivo. Notably, the glycolytic subtype is able to be transformed into the ketolytic subtype in p53-mutated tumors upon glucose limitation, rendering resistance to ketogenic therapy associated with upregulation of ketolytic enzymes, such as OXCT1 by mutant p53. The allosteric activator of mutant p53 effectively blocks the rewired molecular expression and the reprogrammed metabolism, leading to the suppression of tumor growth. The findings highlight the utility of metabolic subtyping to guide ketogenic therapy in colon cancer and identify mutant p53 as a synthetic lethality target for ketogenic treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.